The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib study of afatinib plus standard-dose cetuximab in patients (pts) with advanced solid tumors.
 
Anas Gazzah
No Relationships to Disclose
 
Valentina Boni
No Relationships to Disclose
 
Jean-Charles Soria
Honoraria - BBI Healthcare; Roche Pharma AG
 
Esther Holgado
Honoraria - Roche Pharma AG
Consulting or Advisory Role - Roche Pharma AG
Travel, Accommodations, Expenses - Merck Serono; Roche Pharma AG
 
Caroline Even
No Relationships to Disclose
 
Mahmoud Ould Kaci
Employment - Boehringer Ingelheim
 
Serge Nazabadioko
Employment - Boehringer Ingelheim
 
Wenqiong Xue
Employment - Boehringer Ingelheim
 
Emiliano Calvo
Consulting or Advisory Role - Astellas Pharma; GlaxoSmithKline; Lilly/ImClone; Nanobiotix; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - Novartis
Research Funding - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Janssen Oncology; Lilly; Merck; Millennium; Nektar; Novartis; OncoMed; Pfizer; PharmaMar; PsiOxus Therapeutics; Puma Biotechnology; Roche/Genentech; Sanofi; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Lilly; Novartis; PsiOxus Therapeutics